Thermo Fisher Scientific will be at CPHI Barcelona, October 24-26. Find us at booth #3K50 or schedule a meeting today.
mRNA is being explored as a therapeutic strategy for a variety of clinical applications, including infectious disease, protein replacement, and immuno-oncology, among others.
But despite its inherent advantages, several challenges still exist, including:
Our interactive article explores each industry challenge in detail and examines avenues to overcome them.